“This process provides new manufacturers with established products the opportunity to quickly enter the VietNamese market and help with the COVID fight while also establishing themselves in a growing market of 100 million people.”

David Vo
General Manager
Asia Actual VietNam

Come grow with us in the US in Thailand in China in Korea in the Philippines in Taiwan in Hong Kong

Sources and Links

VietNam Expedites Registration of COVID-19 Related Medical Devices

Published on: October 4th, 2021

With the release of Circular 13/2021/TT-BYT on September 16, 2021, the VietNamese Ministry of Health has provided a new, expedited review process for specified medical devices related to COVID-19. Qualifying applications will be reviewed in 10 days and will need to be renewed by the end of 2022. Products listed as essential to fighting COVID-19 and are eligible for an expedited registration route are:

  1. Extraction machine
  2. PCR machine
  3. Chemicals (biological products) used with the PCR machine to test for SARS-Co V-2
  4. Anti-SARS-Co V-2 antigen/antibody rapid test kits
  5. Invasive and non-invasive ventilators (high function, high flow, portable, etc.)
  6. Continuous dialysis machine
  7. Portable x-ray machine
  8. Color Doppler ultrasound machine (3 probes)
  9. Blood gas meter (measuring electrolytes, lactate, and hematocrits)
  10. Patient monitor (5 parameters)
  11. Electric injection pump
  12. Infusion machine
  13. Pacemaker/Defibrillator
  14. Electrocardiogram (6 channels)
  15. Portable ultrasound machine
  16. Coagulation time meter
  17. Hemodynamic meter

Qualifying Products

Not all products will be reviewed under the fast track, abbreviated review process in VietNam. Products must meet one of the following to submit under this registration route:

  1. Has been allowed to circulate or use by one of the following organizations (US FDA, TGA, Health Canada, MHLW, PMDA)
  2. It has been regulated by the competent authorities of the European countries specified in Appendix 2 to this Circular for permission for circulation and emergency use;
  3. Belonging to the list of SARS-CoV-2 testing products that are used urgently issued by the World Health Organization (WHO)
  4. Belonging to the list of popular products for testing SARS-CoV-2 due to issued by the European Health Security Committee (EUHSC)
  5. Having been granted a commercial import license in VietNam South before the effective date of this Circular
  6. Produced domestically in the form of technology transfer and meets criteria mentioned in points a) through e)
  7. Produced domestically in the form of processing for medical equipment economy and meets criteria mentioned in points a) through e)

This process provides new manufacturers with established products the opportunity to quickly enter the VietNamese market and help with the COVID fight while also establishing themselves in a growing market of 100 million people.

Come Grow With Us

Asia Actual specializes in helping medical device manufacturers grow their sales in Asia with experienced, bi-lingual commercial and regulatory experts on the ground in each market.

Contact Asia Actual today with any questions or support requests.

Blog Posts

China Fully Implements UDI Requirements for Class 3 Medical Devices

Beginning January 1, 2021, the NMPA began implementing UDI requirements in China for the first batch of 69 types of medical devices in 9 categories.

Korea MFDS Implements Medical Device Monthly Reporting Requirements

The Korean MFDS now requires all Class II, III, and IV medical devices submit monthly installation reports via an online portal.

Philippines FDA Bans Mercury-Added Products

Released on June 13, 2022, the Philippines FDA released FDA Circular No.2022-003 banning the manufacture and sale of mercury-added products including thermometers, sphygmomanometers, dental amalgam capsules and liquid mercury for use in dental restorative purposes.